CSIR collaborates with Aurobindo Pharma to develop Covid-19 vaccines

As per the release issued by the Centre for Cellular & Molecular Biology (CCMB), under the signed agreement between CSIR- CCMB and Aurobindo Pharma, Aurobindo will partner with CSIR for the development of several novel Covid-19 vaccines.

from Hindustan Times - india https://ift.tt/33qrC84